Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNAs as biomarkers for monitoring cardiovascular changes in Type II Diabetes Mellitus (T2DM) and exercise

7 Jul 2022

Abstract excerpt

Introduction: MicroRNAs (miRNAs) have been shown to be altered in both CVD and T2DM and can have an application as diagnostic and prognostic biomarkers. miRNAs are released into circulation when the cardiomyocyte is subjected to injury and damage. Objectives: Measuring circulating miRNA levels in human plasma may be of great potential use for measuring the extent of damage to cardiomyocytes and response to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Exercise and Physiological Responses
Share to Hydrogen's biological and therapeutic effects
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35818628
DOI: 10.1007/s40200-022-01066-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNAs as biomarkers for monitoring cardiovascular changes in Type II Diabetes Mellitus (T2DM) and exercisePMID 35818628Read ↗

Exercise Training-Induced Changes in MicroRNAs: Beneficial Regulatory Effects in Hypertension, Type 2 Diabetes, and ObesitySemantic proximity Read ↗

MicroRNAs and Cardiovascular Disease in Diabetes Mellitus.Semantic proximity Read ↗

MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeuticsSemantic proximity Read ↗

The role of microRNAs in the pathophysiology, diagnosis, and treatment of diabetic cardiomyopathySemantic proximity Read ↗

Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathySemantic proximity Read ↗

Dysregulation of circulating miRNAs promotes the pathogenesis of diabetes-induced cardiomyopathy.Semantic proximity Read ↗

Serum miRNA Profile in Diabetic Patients With Ischemic Heart Disease as a Promising Non-Invasive BiomarkerSemantic proximity Read ↗

MicroRNAs in Obesity-Associated Disorders: The Role of Exercise TrainingSemantic proximity Read ↗

Serum miRNA Profile in Diabetic Patients with Ischemic Heart Disease as a Promising non-invasive BiomarkerSemantic proximity Read ↗

MicroRNA: unveiling novel mechanistic and theranostic pathways in diabetic cardiomyopathySemantic proximity Read ↗

The involvement of microRNAs in Type 2 diabetesSemantic proximity Read ↗

Role of microRNAs in the pathogenesis of diabetic cardiomyopathySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.